mesalazine 1.2 takeda (mesalazine) 1.2 g prolonged release tablet blister pack
takeda pharmaceuticals australia pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: methacrylic acid copolymer; purified talc; silicon dioxide; sodium starch glycollate; stearic acid; iron oxide red; carmellose sodium; carnauba wax; magnesium stearate; titanium dioxide; macrogol 6000; triethyl citrate - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.
calcigran
takeda austria gmbh, austria - chewable tablet - 1250, 8 mg - calcium carbonate, cholecalciferol concentrate
alunbrig 30 mg
takeda israel ltd - brigatinib - film coated tablets - brigatinib 30 mg - brigatinib - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc)
alunbrig 90 mg
takeda israel ltd - brigatinib - film coated tablets - brigatinib 90 mg - brigatinib - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc)
human albumin takeda 200 mgml solution for infusion
takeda israel ltd - albumin human - solution for infusion - albumin human 200 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.
human albumin takeda 50 mgml solution for infusion
takeda israel ltd - albumin human - solution for infusion - albumin human 50 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.
condyline paint, bottle
celltrion healthcare australia pty ltd - podophyllotoxin, quantity: 5 mg/ml - solution - excipient ingredients: ethanol; (s)-lactic acid; sodium (s)-lactate; purified water - for the treatment of anogenital warts.
condyline 0.5% %w/v cutaneous solution
takeda uk limited - podophyllotoxin - cutaneous solution - 0.5% %w/v - antivirals
advate 1000 iu powder and solvent for solution for injection powder, for solution
takeda austria gmbh, austria - recombinant coagulation factor viii (octocog alfa) - powder, for solution - 1000 iu
dexlansoprazole takeda 30 milligram capsules modified release
takeda pharma a/s - dexlansoprazole - capsules modified release - 30 milligram